Agucare 对比 MCSAID 的使用情况和统计数据

It is a safe, user-friendly telemedicine platform that creates a direct channel between the health professional and the patient, with all the necessary functionalities to be able to carry out a correct consultation and follow-up of the patient's treatment. It is an indispensable tool in the new form of doctor-patient relationship. Among the main functionalities considered are: video calls for teleconsultation, direct chat between doctor-patient that maintains the privacy and confidentiality of face-to-face care; generation of medical orders for procedures / exams and prescriptions, record of care per patient, personalized system of notifications of continuity of treatment.
  • Google Play 商店
  • 免费
  • 医疗

商店排名

- -

MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for patients with cardiogenic shock. A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the common devices used for hemodynamic support in unstable patients. There is an algorithm for helping understand the decision process depending on key clinical variables such as cardiac output and PAPI. There are also several weaning and escalation algorithm. A calculator section is available for some common hemodynamic variables used in MCS decision-making and is available for quick-reference throughout the algorithm. MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.
  • Google Play 商店
  • 免费
  • 医疗

商店排名

- -

Agucare与MCSAID排名比较

对比 Agucare 与 MCSAID 在过去 28 天内的排名趋势

排名

没有可用的数据

Agucare 对比 MCSAID 的排名,按国家/地区比较

对比 Agucare 与 MCSAID 在过去 28 天内的排名趋势

所有品类

没有可用的数据

医疗

应用
热门国家/地区
排名
#34
- -
- -

通过免费试用版比较任何网站

开始使用
Agucare VS.
MCSAID

十二月 10, 2024